Literature DB >> 22476801

[Secondary malignancies in urinary diversions].

T Kälble1, I Hofmann, J W Thüroff, R Stein, R Hautmann, H Riedmiller, D Vergho, L Hertle, C Wülfing, M Truß, S Roth, F C von Rundstedt, P Albers, J Gschwend, K Herkommer, U Humke, M Spahn, P Bader, J Steffens, R Harzmann, C G Stief, A Karl, S C Müller, M Waldner, J Noldus, K Kleinschmidt, P Alken, B Kopper, M Fisch, A Lampel, A Stenzel, J Fichtner, B Flath, H Rübben, K P Juenemann, S Hautmann, A Knipper, D Leusmann, W Strohmaier, W F Thon, S Miller, K Weingärtner, A Schilling, H Piechota, J E Becht, H Schwaibold, P Bub, S Conrad, U Wenderoth, W Merkle, W Rösch, T Otto, B Ulshöfer, M Westenfelder.   

Abstract

In contrast to ureterosigmoidostomy no reliable clinical data exist for tumor risk in different forms of urinary diversion using isolated intestinal segments.In 44 German urological departments, operation frequencies, indications, patient age, and operation dates of the different forms of urinary diversion, operated between 1970 and 2007, could be registered. The secondary tumors up to 2009 were registered as well and related to the numbers of the different forms of urinary diversions resulting in tumor prevalences.In 17,758 urinary diversions 32 secondary tumors occurred. The tumor risk in ureterosigmoidostomy (22-fold) and cystoplasty (13-fold) is significantly higher than in other continent forms of urinary diversion such as neobladders or pouches (p<0.0001). The difference between ureterosigmoidostomy and cystoplasty is not significant, nor is the difference between ileocecal pouches (0.14%) and ileal neobladders (0.05%) (p=0.46). The tumor risk in ileocecal (1.26%) and colonic neobladders (1.43%) is significantly higher (p=0.0001) than in ileal neobladders (0.5%). Of the 16 tumors that occurred following ureterosigmoidostomy, 16 (94%) developed directly at the ureterocolonic borderline in contrast to only 50% following urinary diversions via isolated intestinal segments.From postoperative year 5 regular endoscopic controls of ureterosigmoidostomies, cystoplasties, and orthotopic (ileo-)colonic neobladders are necessary. In ileocecal pouches, regular endoscopy is necessary at least in the presence of symptoms or should be performed routinely at greater intervals. Following neobladders or conduits, only urethroscopies for urethral recurrence are necessary.

Entities:  

Mesh:

Year:  2012        PMID: 22476801     DOI: 10.1007/s00120-012-2815-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  21 in total

1.  Indiana pouch urinary diversion for adenocarcinoma developing after ureterosigmoidostomy.

Authors:  S Han; J R Starling; D F Jarrard
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

2.  Late malignant change in an ileal conduit.

Authors:  Sally Wielding; Paul Fineron; Peter J Driscoll; David N Anderson
Journal:  Int J Urol       Date:  2008-01       Impact factor: 3.369

3.  Tumor growth in urinary diversion: a multicenter analysis.

Authors:  Tilman Kälble; Ines Hofmann; Hubertus Riedmiller; Daniel Vergho
Journal:  Eur Urol       Date:  2011-07-14       Impact factor: 20.096

4.  Tumor induction in a rat model for ureterosigmoidostomy without evidence of nitrosamine formation.

Authors:  T Kälble; A R Tricker; M Berger; F Amelung; R Waldherr; L Hothorn; K Möhring; G Staehler
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

5.  Tubulovillous adenoma developing after urinary reconstruction using ileal segments.

Authors:  Yuta Yamada; Tetsuya Fujimura; Satoru Takahashi; Takumi Takeuchi; Yutaka Takazawa; Tadaichi Kitamura
Journal:  Int J Urol       Date:  2006-08       Impact factor: 3.369

6.  [Cancer induction by urinary drainage or diversion through intestinal segments?].

Authors:  R Harzmann; B Kopper; P Carl
Journal:  Urologe A       Date:  1986-07       Impact factor: 0.639

Review 7.  Secondary malignancies in different forms of urinary diversion using isolated gut.

Authors:  M Austen; T Kälble
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

8.  Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder.

Authors:  Trevor M Soergel; Mark P Cain; Rosalia Misseri; Thomas A Gardner; Michael O Koch; Richard C Rink
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

9.  Adenocarcinoma at the ureterosigmoidostomy site in a 16-year-old demonstrates the importance of screening in children.

Authors:  Naima Smeulders; Nada Sudhakaran; Duncan T Wilcox; Philip G Ransley
Journal:  J Pediatr Urol       Date:  2007-11-26       Impact factor: 1.830

10.  Long-term outcome of ureterosigmoidostomy: an analysis of patients with >10 years of follow-up.

Authors:  Matthew K Tollefson; Daniel S Elliott; Horst Zincke; Igor Frank
Journal:  BJU Int       Date:  2009-08-13       Impact factor: 5.588

View more
  3 in total

Review 1.  The evaluation and management of refractory neurogenic overactive bladder.

Authors:  Raj Kurpad; Michael J Kennelly
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

Review 2.  [Follow-up of bladder cancer : The right examinations at the right time].

Authors:  P Olbert; P J Goebell; A Hegele
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

3.  [Follow-up care - consequences of urinary diversion after bladder cancer].

Authors:  S Degener; S Roth; M J Mathers; B Ubrig
Journal:  Urologe A       Date:  2014-02       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.